Green Thumb Industries Inc (GTII.CN) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN CA39342L1085

Price
6.32 CAD
Market cap
1.53 bn CAD
P/E (2025)
–
P/S (2025)
1.30
Dividend yield
0.00 %
Net margin
9.71 %
Return on equity (ROE)
5.99 %
Return on assets (ROA)
4.09 %

Green Thumb Industries Inc financials

Fiscal year20242025
Revenue1.14 bn USD1.18 bn USD
Gross profit601.00 m USD574.89 m USD
Operating income–137.70 m USD
EBIT224.00 m USD–
Net income73.00 m USD114.15 m USD
Diluted EPS – continuing operations0.30 USD–

Full history since 2001, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Green Thumb Industries Inc

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products to third-party licensed retail cannabis stores. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.